Literature DB >> 29747125

A characterization of pro-inflammatory cytokines in dextran sulfate sodium-induced chronic relapsing colitis mice model.

Yan-Hong Li1, Rosenstein Adam2, Jean-Frederic Colombel2, Zhao-Xiang Bian3.   

Abstract

Repeated cycles of dextran sulfate sodium (DSS) administration in mice, inducing chronic relapsing colitis, have been used to mimic human ulcerative colitis (UC). However, no systematic characterization of pro-inflammatory cytokines in these DSS mice has been reported. In this study, the development of colitis was examined by assessment of the disease severity and inflammation in the colon of C57BL/6 mice that received DSS. ELISA was used to analyze the levels of pro-inflammatory cytokines in serum, colon, spleen and supernatant of cultured splenocytes. mRNA levels of the above cytokines in colon and mesenteric lymph node (MLN) were measured with RT-PCR. The mice receiving three cycles of 2% DSS over a 43-day period showed a fluctuating appearance of diarrhea and bloody feces, and a significant reduction in body weight and colon length. When compared with normal control mice, an increase in TNF-α level in serum was detected in the DSS mice, along with a decrease in the amounts of TNF-α, IL-17, IL-1β and IL-6 in the colonic tissue. However, mRNA levels of these cytokines were found to be significantly increased in the colon while decreased in the MLN of the colitis mice. Further, the ELISA assay suggested a pronounced increase of TNF-α production by cultured splenocytes with PMA/ionomycin re-stimulation but no increase in its presence in spleen tissue upon DSS challenge. In conclusion, we have systematically demonstrated the dysregulation of pro-inflammatory cytokines in the DSS-induced chronic relapsing colitis model, which will provide markers to test emerging therapeutic strategies by this model.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chronic relapsing colitis; Dextran sulfate sodium; Mice; Pro-inflammatory cytokines

Mesh:

Substances:

Year:  2018        PMID: 29747125     DOI: 10.1016/j.intimp.2018.05.001

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  10 in total

1.  Berberine inhibits IFN-γ signaling pathway in DSS-induced ulcerative colitis.

Authors:  Tao Yang; Xiao Ma; Ruilin Wang; Honghong Liu; Shizhang Wei; Manyi Jing; Haotian Li; Yanling Zhao
Journal:  Saudi Pharm J       Date:  2022-04-01       Impact factor: 4.562

2.  Investigating Gut Permeability in Animal Models of Disease.

Authors:  Marianela González-González; Camilo Díaz-Zepeda; Johana Eyzaguirre-Velásquez; Camila González-Arancibia; Javier A Bravo; Marcela Julio-Pieper
Journal:  Front Physiol       Date:  2019-01-15       Impact factor: 4.566

3.  BG-4 from Bitter Gourd (Momordica charantia) Differentially Affects Inflammation In Vitro and In Vivo.

Authors:  Andrea Nieto-Veloza; Zhihong Wang; Qixin Zhong; Hari B Krishnan; Vermont P Dia
Journal:  Antioxidants (Basel)       Date:  2019-06-14

4.  Inhibitor of Differentiation-2 Protein Ameliorates DSS-Induced Ulcerative Colitis by Inhibiting NF-κB Activation in Neutrophils.

Authors:  Jie Ren; Dong Yan; Yichun Wang; Jiaojiao Zhang; Min Li; Wancheng Xiong; Xueqian Jing; Puze Li; Weidong Zhao; Xiwen Xiong; Minna Wu; Genshen Zhong
Journal:  Front Immunol       Date:  2021-11-04       Impact factor: 7.561

5.  Revealing the Mechanism of Friedelin in the Treatment of Ulcerative Colitis Based on Network Pharmacology and Experimental Verification.

Authors:  Bei Shi; Suxian Liu; Aoshuang Huang; Mengyun Zhou; Boyun Sun; Hui Cao; Jingyi Shan; Bo Sun; Jiang Lin
Journal:  Evid Based Complement Alternat Med       Date:  2021-11-02       Impact factor: 2.629

6.  Stressor-Induced Increases in Circulating, but Not Colonic, Cytokines Are Related to Anxiety-like Behavior and Hippocampal Inflammation in a Murine Colitis Model.

Authors:  Ross M Maltz; Pedro Marte-Ortiz; Therese A Rajasekera; Brett R Loman; Tamar L Gur; Michael T Bailey
Journal:  Int J Mol Sci       Date:  2022-02-11       Impact factor: 5.923

7.  Wu-Mei-Wan Ameliorates Murine Ulcerative Colitis by Regulating Macrophage Polarization.

Authors:  Shuguang Yan; Hailiang Wei; Rui Jia; Meijia Zhen; Shengchuan Bao; Wenba Wang; Fanrong Liu; Jingtao Li
Journal:  Front Pharmacol       Date:  2022-03-21       Impact factor: 5.810

8.  Galactooligosaccharide Treatment Alleviates DSS-Induced Colonic Inflammation in Caco-2 Cell Model.

Authors:  Marianna Roselli; Aleksandra Maruszak; Roberta Grimaldi; Lucien Harthoorn; Alberto Finamore
Journal:  Front Nutr       Date:  2022-04-14

9.  Idebenone Protects against Acute Murine Colitis via Antioxidant and Anti-Inflammatory Mechanisms.

Authors:  Sonia Shastri; Tanvi Shinde; Sukhwinder Singh Sohal; Nuri Gueven; Rajaraman Eri
Journal:  Int J Mol Sci       Date:  2020-01-12       Impact factor: 5.923

10.  Resistant Maltodextrin Alleviates Dextran Sulfate Sodium-Induced Intestinal Inflammatory Injury by Increasing Butyric Acid to Inhibit Proinflammatory Cytokine Levels.

Authors:  Shilan Wang; Shiyi Zhang; Shimeng Huang; Zhenhua Wu; Jiaman Pang; Yujun Wu; Junjun Wang; Dandan Han
Journal:  Biomed Res Int       Date:  2020-09-16       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.